Vericel Corporation (NASDAQ: VCEL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT VERICEL CORPORATION

Vericel Corporation (NASDAQ: VCEL)
Listen to this Section


$36.30
N/A ( 0% ) 0.0K

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Market Data


Open $36.30
Previous Close $36.30
Volume 0.0K
Market Cap $1.85B
Day Range $35.47 - $36.57
52 Week Range $28.95 - $45.97
Shares Outstanding 51.07M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year1997
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2025
4 Insider transactions 1 Nov 12, 2025
4 Insider transactions 1 Nov 10, 2025
8-k 8K-related 15 Nov 06, 2025
10-q Quarterly Reports 65 Nov 06, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Aug 08, 2025
8-k 8K-related 15 Jul 31, 2025
10-q Quarterly Reports 68 Jul 31, 2025

Latest News


× Before browsing our site, please accept our cookies policy